Product NewsDrug discovery > Clinical Development Oxford Biomedica secures agreement with FDA on special protocol assessment for phase III trial of TroVax in renal cancer
Product NewsDrug discovery > Clinical Development BioAlliance Pharma starts pivotal Phase III clinical trial in the US of Loramyc® treatment for oropharyngeal candidiasis
Product NewsDrug discovery > Clinical Development BioAlliance Pharma démarre une étude clinique pivot de phase III aux Etats-Unis pour le Loramyc® dans le traitement de la candidose oropharyngée
Product NewsDrug discovery > Clinical Development ClinPhone and HTS Introduce New Memory Enhancing Technique to Improve Reliability of Clinical Trial Results
Product NewsClinical Diagnostics Russian Neonatal Screening Laboratories to Boost Scope and Capacity with New PerkinElmer Reagents and Technologies
Product NewsDrug discovery > Clinical Development Faust Pharmaceuticals announces Phase IIa clinical trial results for treatment of amyotrophic lateral sclerosis (ALS)
Product NewsLife Sciences Unmet Medical Needs, Positive Regulatory Frameworks and Increased Investments Support Continued Stem Cell Research
Product NewsDrug discovery > Lead Discovery TopoTarget reports promising Phase II trial results with Avugane™ in acne vulgaris
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsDrug discovery > Lead Discovery PowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsLife Sciences Acolyte Biomedica introduces BacLite®flex system for rapid MRSA screening at the London Independent Hospital
Product NewsDrug discovery > Lead Discovery Astech Projects’ new automated inhaler tester accommodates any design
Product NewsLife Sciences Oxford Biomedica plc preliminary results for the year ended 31 December 2005
Product NewsLab Informatics Quest Diagnostics' Enhanced Care360™ Physician Portal Combines Laboratory Test Results and Prescription Data to Help Doctors Evaluate Patients' Response to Medication Therapy
Product NewsDrug discovery > Lead Discovery TopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsDrug discovery > Lead Discovery Hybrigenics acquires worldwide rights to inecalcitol, a vitamin D analogue
Product NewsLife Sciences Olympus introduces cost effective microdissection technology for precise routine work
Product NewsDrug discovery > Lead Discovery Oxford Immunotec’s T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients
Product NewsDrug discovery > Clinical Development ARDANA’S NOVEL TESTOSTERONE CREAM REMAINS ON TRACK FOR Q4 2007 LAUNCH FOLLOWING PRE-IND MEETING WITH US FDA.
Product NewsDrug discovery > Clinical Development TopoTarget and CuraGen initiate Phase II Trial with PXD101 for T-Cell Lymphomas (TCLs)
